SMS Lifesciences India Ltd
Pharmaceuticals & Biotechnology | Small Cap
SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio3.80
- Profitability Ratio9.80
- Efficiency Ratio3.33
- Coverage Ratio8.80
- Solvency Ratio10.00
- Liquidity Ratio3.08
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthBullish
SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.
Overall Valuation Score
P/E RATIO (TTM)
23.42
Industry Median
28.93
Small Cap Median
26.92
P/E RATIO
21.78
P/B RATIO
2.12
Industry Median
3.18
Small Cap Median
2.63
P/S RATIO
1.26
Industry Median
3.41
Small Cap Median
2.40
Others
PEG RATIO
1.49
EV/EBITDA RATIO
8.69
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1448.5 as on Jun 18, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth ratios display a strong upward trend, showing SMS Lifesciences is significantly expanding. High growth in revenue, operating profit, EPS, assets, and net income indicates robust business performance. This growth reflects effective strategies and market positioning. The company is experiencing substantial expansion across various financial metrics. The weighted average calculation underscores the consistent and strong growth trajectory.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 1.92 | 31.58 | -9.71 | -3.16 | 12.75 |
| Operating Profit Growth Rate | 20 | 16.67 | -17.14 | 6.9 | 45.16 |
| Earnings Per Share (EPS) Growth | 33.2 | 86.73 | -54.73 | -20.68 | 121.22 |
| Asset Growth Rate | N/A | 18.21 | 10.64 | -1.01 | -0.26 |
| Net Income Growth Rate | 40 | 78.57 | -56 | -45.45 | 216.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios is mixed, showing inconsistent performance across key metrics. While the book value per share is average, adjusted EPS, cash EPS, and dividend per share are relatively low. Capital expenditures are a concern, suggesting potential underinvestment. These factors collectively impact the company's overall financial health and long-term sustainability. It might face challenges in securing funding for future projects. The weighted average calculation highlights the mixed performance across these financial metrics.
| Financial Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 46.67 | 83.33 | 36.67 | 20 | 63.33 |
| Cash Earnings Per Share (Cash EPS) | 73.33 | 116.67 | 73.33 | 70 | 113.33 |
| Book Value Per Share | 430 | 506.67 | 563.33 | 590 | 656.67 |
| Dividend Per Share (DPS) | 1.35 | 1.68 | 1.52 | 1.5 | 1.33 |
| Capital Expenditures (CapEx) | 35.5 | 41.5 | 42.8 | 20.8 | 15 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability ratios demonstrate a strong ability to generate profits. High gross profit margin, ROCE, ROE, ROA, operating margin, and net margin indicate efficient operations and effective management. This profitability reflects the company's ability to control costs and maximize revenue. This ensures long-term sustainability and shareholder value. The weighted average calculation highlights the consistent strength in profitability metrics.
| Profitability Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.27 | 7.14 | 5.7 | 5.23 | 8.7 |
| Return on Capital Employed (ROCE) | 10.73 | 14.23 | 7.36 | 6.37 | 11.55 |
| Return on Equity (ROE) | 10.85 | 16.43 | 6.46 | 1.82 | 8.94 |
| Return on Assets (ROA) | 9.93 | 9.8 | 7.34 | 7.93 | 11.54 |
| Operating Margin | 11.28 | 10 | 9.18 | 10.13 | 13.04 |
| Net Margin | 5.26 | 7.14 | 3.48 | 1.96 | 5.51 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios indicate mixed performance in asset utilization. While the receivables turnover is average, the fixed asset and capital turnover ratios suggest underutilization of assets. High days sales in inventory and receivable days indicate potential inefficiencies in inventory and credit management. These factors may impact the company's ability to generate revenue from its asset base. It also means money is tight because sales are taking more time. The weighted average calculation highlights the recent challenges in optimizing asset utilization.
| Efficiency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.05 | 2.46 | 1.39 | 1.37 | 1.49 |
| Inventory Turnover Ratio | 7.84 | 4.44 | 3.49 | 3.47 | 4.26 |
| Receivables Turnover Ratio | 15.65 | 10.29 | 7.9 | 6.31 | 5.75 |
| Days Sales in Inventory Ratio | 46.56 | 82.21 | 104.58 | 105.19 | 85.68 |
| Receivable Days | 23.32 | 35.47 | 46.2 | 57.84 | 63.48 |
| Capital Turnover Ratio | 1.14 | 1.28 | 0.97 | 0.97 | 1.14 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios is strong, indicating a good ability to meet its interest and dividend obligations. The interest coverage ratio suggests the company can comfortably pay its interest expenses from its earnings. High dividend coverage indicates a high capacity to cover dividend payments. This showcases financial stability and security for investors. The weighted average calculation highlights the consistent strength in meeting coverage obligations.
| Coverage Ratios | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Interest Coverage Ratio | 4 | 5 | 6.5 | 3.43 | 2 | 3.89 |
| Equity Dividend Coverage Ratio | N/A | 33.33 | 50 | 25 | 20 | 50 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency ratios reflect a strong position, indicating a healthy balance between debt and equity. The low debt ratio and debt-to-equity ratio suggest that the company relies more on equity than debt to finance its assets. The high equity ratio further confirms the financial stability and lower risk of financial distress. The improving debt to asset ratio demonstrates controlled use of debt. This indicates long-term financial stability and resilience. The weighted average calculation underscores the continued strength in solvency management.
| Solvency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debt Ratio | 0.23 | 0.22 | 0.25 | 0.17 | 0.09 |
| Debt to Equity Ratio | 0.3 | 0.28 | 0.33 | 0.2 | 0.1 |
| Equity Ratio | 0.77 | 0.78 | 0.75 | 0.83 | 0.91 |
| Debt To Asset Ratio | 0.13 | 0.12 | 0.14 | 0.09 | 0.05 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position reflects challenges in meeting short-term obligations. The current and cash ratios indicate limited ability to cover immediate liabilities with current assets and cash. The quick ratio offers a slightly better, but still weak, view when excluding inventory. The operating cash flow ratio, while slightly better, could be improved to enhance the company's short-term financial health. These ratios collectively suggest potential difficulties in managing working capital effectively. The weighted average calculation places emphasis on recent performance, highlighting the need for improvement in liquidity management.
| Liquidity Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Current Ratio | 1.01 | 1.01 | 0.98 | 0.91 | 0.91 |
| Quick Ratio | 0.54 | 0.49 | 0.47 | 0.45 | 0.53 |
| Cash Ratio | 0.08 | 0.02 | 0.02 | 0.01 | 0.01 |
| Operating Cash Flow Ratio | 0.26 | -0.07 | 0.09 | 0.13 | 0.2 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 2 | Kilitch Drugs (India) Ltd | 6.61 | 21.17 | Neutral | 37.00 | 9.27 | 30.00 |
| 3 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 4 | SMS Lifesciences India Ltd | 6.59 | 21.78 | Neutral | 45.00 | 70.68 | 19.00 |
| 5 | Infinium Pharmachem Ltd | 6.42 | 26.49 | Neutral | 22.00 | 6.43 | 14.00 |
| 6 | Medicamen Biotech Ltd | 5.73 | 31.76 | Neutral | 20.00 | 6.94 | 10.00 |
| 7 | Aarey Drugs & Pharmaceuticals Ltd | 5.73 | 58.49 | Neutral | 7.00 | 1.40 | 4.00 |
| 8 | Albert David Ltd | 5.63 | -272.76 | Neutral | 5.00 | -2.62 | -1.00 |
| 9 | BPL Ltd | 5.46 | -31.34 | Neutral | -4.82 | -3.00 | -8.55 |
| 10 | Zim Laboratories Ltd | 5.41 | 41.96 | Neutral | 30.00 | 1.11 | 6.00 |
| 11 | Lyka Labs Ltd | 4.77 | -24.93 | Neutral | -4.00 | -9.05 | -10.00 |
| 12 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
The management of SMS Lifesciences demonstrates a mixed performance. Revenue growth has been inconsistent, with a recent increase in sales offset by earlier declines. Profitability margins vary, and while there's been recent YOY profit growth, it follows a period of significant declines. Capital efficiency, as indicated by ROCE and ROE, is modest but has shown improvement. The company's debt management shows some control, but interest coverage could be better. Promoter holding is high, indicating confidence. Overall, SMS Lifesciences shows potential but needs consistent improvements in both sales and profitability.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Promoter Holding | 71.40% | High promoter holding indicates strong management alignment |
| PROS | Sales Growth 2025 | 12.67% | Shows recovery in revenue generation |
| CONS | Interest Coverage Ratio (2024) | 3.1 | Indicates potential challenges in meeting interest obligations |
| CONS | ROCE (2024) | 7% | Suggests suboptimal capital allocation efficiency |
Financial Performance & Growth
Sales growth has been inconsistent. Compounded Sales Growth shows a negative trend in the recent 3 years. Profit growth has been volatile. While TTM Compounded Profit Growth is high, previous years show fluctuations. Quarterly YOY Profit Growth % shows significant volatility, with highs and lows. OPM % varies across quarters, indicating instability in operational efficiency. Other Income Contribution is relatively low compared to Net Profit and PBT, suggesting that profit primarily comes from core operations.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Sales Growth % | 31.81% | -9.86% | -3.04% | 12.67% |
Capital Efficiency & Returns
ROCE has fluctuated over the years. ROE has also varied, indicating inconsistent returns on shareholder funds. The company needs to improve its capital efficiency and returns. Asset turnover isn't explicitly provided, limiting this analysis. Cash Conversion Cycle is high, indicating inefficiencies in working capital management.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE % | 12% | 13% | 12% | 8% | 7% | 12% |
Financial Health & Prudence
Interest coverage can be inferred from Operating Profit and Interest expenses but needs improvement. The company has been consistently sharing profits through dividends, but the payout ratio remains low.
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Interest Coverage Ratio (Operating Profit / Interest) | 5.83 | 5 | 6 | 5.83 | 4.14 | 3.1 | 5 |
Shareholding & Ownership Structure
Promoter holding has increased over the years and is currently at a high level, indicating confidence and alignment with shareholders. Institutional Holding (FII/DII) is minimal to none, which could be a point of concern or an opportunity for growth.
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding % | 67.99% | 67.99% | 68.00% | 68.26% | 68.96% | 70.32% | 71.19% | 71.40% |
The risk assessment for SMS Lifesciences indicates a moderate level of concern. The company's working capital management needs improvement, as indicated by the high cash conversion cycle. However, promoter holding is strong, indicating confidence. Overall, SMS Lifesciences faces risks related to operational efficiency and financial stability, but these are somewhat mitigated by strong promoter backing.
Working Capital Management
Cash Conversion Cycle is high and has increased over the years, indicating inefficiencies in working capital management and a higher risk profile. The company needs to optimize its working capital cycle to improve financial health.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Cash Conversion Cycle | 16 | 78 | 48 | 48 | 110 | 115 | 106 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 101451.10Bearish
- SMA 201427.86Bullish
- SMA 501416.70Bullish
- EMA 101442.02Bearish
- EMA 201434.98Bearish
- EMA 501425.44Bullish
- DEMA 101447.07Bearish
- DEMA 201447.65Bearish
- DEMA 501423.95Bullish
- TEMA 101442.47Bearish
- TEMA 201451.23Bearish
- TEMA 501447.79Bearish
- MACD9.37Bearish
- ADX22.40Weak Trend
- IndicatorValueSignal
- RSI50.78Neutral
- CCI19.83Neutral
- ROC 9-2.25Bearish
- ROC 142.48Bullish
- ROC 25-0.30Bearish
- Stoch K54.81Neutral
- Stoch D67.31Neutral
- IndicatorValueSignal
- BB Upper1488.07Neutral
- BB Middle1427.85Neutral
- BB Lower1367.64Neutral
- ATR23.19Low Volatility
- IndicatorValueSignal
- MFI80.77Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101432.98Bullish
- SMA 201421.60Bullish
- SMA 501405.60Bullish
- EMA 101435.08Bearish
- EMA 201425.53Bullish
- EMA 501432.97Bullish
- DEMA 101446.49Bearish
- DEMA 201436.62Bearish
- DEMA 501400.90Bullish
- TEMA 101447.87Bearish
- TEMA 201450.84Bearish
- TEMA 501404.75Bullish
- MACD9.23Bullish
- ADX21.18Weak Trend
- IndicatorValueSignal
- RSI51.86Neutral
- CCI30.74Neutral
- ROC 94.60Bullish
- ROC 14-0.24Bearish
- ROC 253.50Bullish
- Stoch K67.76Neutral
- Stoch D69.57Neutral
- IndicatorValueSignal
- BB Upper1475.74Neutral
- BB Middle1421.60Neutral
- BB Lower1367.46Neutral
- ATR34.32Low Volatility
- IndicatorValueSignal
- MFI38.96Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101419.86Bullish
- SMA 201405.91Bullish
- SMA 501489.74Bearish
- EMA 101423.76Bullish
- EMA 201424.94Bullish
- EMA 501452.67Bearish
- DEMA 101433.27Bullish
- DEMA 201406.18Bullish
- DEMA 501442.53Bearish
- TEMA 101443.71Bearish
- TEMA 201424.30Bullish
- TEMA 50N/AN/A
- MACD-9.83Bullish
- ADX14.78Weak Trend
- IndicatorValueSignal
- RSI50.14Neutral
- CCI73.11Neutral
- ROC 91.67Bullish
- ROC 142.36Bullish
- ROC 25-0.72Bearish
- Stoch K68.13Neutral
- Stoch D72.83Neutral
- IndicatorValueSignal
- BB Upper1458.23Neutral
- BB Middle1405.91Neutral
- BB Lower1353.58Neutral
- ATR48.82Low Volatility
- IndicatorValueSignal
- MFI43.58Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 101402.52Bullish
- SMA 201480.12Bearish
- SMA 501459.38Bearish
- SMA 1001357.87Bullish
- SMA 2001294.83Bullish
- EMA 101424.71Bullish
- EMA 201450.42Bearish
- EMA 501442.42Bullish
- EMA 1001391.30Bullish
- EMA 2001327.71Bullish
- DEMA 101400.64Bullish
- DEMA 201418.99Bullish
- DEMA 501494.73Bearish
- DEMA 1001477.23Bearish
- DEMA 2001427.90Bullish
- TEMA 101414.01Bullish
- TEMA 201377.84Bullish
- TEMA 501481.33Bearish
- TEMA 1001510.67Bearish
- TEMA 2001450.17Bearish
- MACD-26.08Bearish
- ADX17.64Weak Trend
- IndicatorValueSignal
- RSI49.05Neutral
- CCI-24.84Neutral
- ROC 14-8.40Bearish
- ROC 25-7.33Bearish
- Stoch K35.09Neutral
- Stoch D26.08Neutral
- IndicatorValueSignal
- BB Upper1705.41Neutral
- BB Middle1480.13Neutral
- BB Lower1254.84Neutral
- ATR86.72Low Volatility
- IndicatorValueSignal
- MFI19.14Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 201366.40Bullish
- SMA 501273.06Bullish
- EMA 201398.19Bullish
- EMA 501309.13Bullish
- DEMA 201484.97Bearish
- DEMA 501421.39Bearish
- TEMA 201519.68Bearish
- TEMA 501433.22Bearish
- MACD67.29Bullish
- ADX24.74Weak Trend
- IndicatorValueSignal
- RSI53.03Neutral
- CCI79.42Neutral
- ROC 1411.34Bullish
- ROC 2515.24Bullish
- Stoch K46.58Neutral
- Stoch D59.43Neutral
- IndicatorValueSignal
- BB Upper1640.04Neutral
- BB Middle1366.40Neutral
- BB Lower1092.76Neutral
- ATR150.96Low Volatility
- IndicatorValueSignal
- MFI68.64Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 61333.18Bullish
- SMA 121265.16Bullish
- SMA 241234.62Bullish
- EMA 61376.46Bullish
- EMA 121299.39Bullish
- EMA 241182.82Bullish
- DEMA 61469.41Bullish
- DEMA 121413.77Bullish
- DEMA 241390.87Bullish
- TEMA 61517.34Bullish
- TEMA 121428.58Bullish
- TEMA 241426.91Bullish
- MACD218.51Bullish
- ADX43.91Strong Trend
- IndicatorValueSignal
- RSI64.34Neutral
- CCI144.48Overbought
- ROC 25127.51Bullish
- ROC 50126.14Bullish
- Stoch K58.11Neutral
- Stoch D60.35Neutral
- IndicatorValueSignal
- BB Upper1500.97Overbought
- BB Middle1248.82Neutral
- BB Lower996.68Neutral
- ATR249.30High Volatility
- IndicatorValueSignal
- MFI49.96Neutral